BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/26/2014 4:36:00 PM | Browse: 1253 | Download: 956
 |
Received |
|
2013-10-14 11:25 |
 |
Peer-Review Started |
|
2013-10-14 15:16 |
 |
To Make the First Decision |
|
2014-01-12 11:03 |
 |
Return for Revision |
|
2014-01-12 13:09 |
 |
Revised |
|
|
 |
Second Decision |
|
2014-03-19 13:43 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-03-19 15:24 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-05-21 16:03 |
 |
Publish the Manuscript Online |
|
2014-06-06 16:55 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Case Report |
Article Title |
Reversible posterior leukoencephalopathy syndrome induced by bevacizumab plus chemotherapy in colorectal cancer
|
Manuscript Source |
Invited Manuscript |
All Author List |
Wei Wang, Li-Rong Zhao, Xiu-Qiang Lin and Fen Feng |
Funding Agency and Grant Number |
|
Corresponding Author |
Fen Feng, MD, Department of Gastroenterology, Foshan First People’s Hospital, No. 81 Lingnan Dadaobei, Chancheng District, Foshan 520800, Guangdong Province, China. ffen@fsyyy.com |
Key Words |
Bevacizumab; Reversible posterior leukoencephalopathy syndrome; Colorectal cancer; Hypertension; Coma |
Core Tip |
This is the first report of reversible posterior leukoencephalopathy syndrome (RPLS) induced by bevacizumab in China. RPLS is a rare complication of bevacizumab, but may present with life-threatening symptoms such as coma. Sudden blood pressure increase is the most common risk factor, and early recognition and prompt control of blood pressure may make this complication reversible. |
Publish Date |
2014-06-06 16:55 |
Citation |
Wang W, Zhao LR, Lin XQ, Feng F. Reversible posterior leukoencephalopathy syndrome induced by bevacizumab plus chemotherapy in colorectal cancer. World J Gastroenterol 2014; 20(21): 6691-6697 |
URL |
http://www.wjgnet.com/1007-9327/full/v20/i21/6691.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v20.i21.6691 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345